Thorsten Simon
Overview
Explore the profile of Thorsten Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
3409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Karbach U, Krawiec S, Remmert S, Toenne R, Reinhardt D, Schneider D, et al.
Klin Padiatr
. 2024 Mar;
236(3):165-172.
PMID: 38437869
Background: About 2,200 children and adolescents in Germany per year are diagnosed with oncological diseases. Through now, there are almost no offers for home care services for these patients. There...
12.
Simon T, Mayr G, Morgenstern D, Umlauf N, Zeileis A
Clim Dyn
. 2023 Oct;
61(9-10):4125-4137.
PMID: 37854482
The response of lightning to a changing climate is not fully understood. Historic trends of proxies known for fostering convective environments suggest an increase of lightning over large parts of...
13.
Flaadt T, Ebinger M, Schreiber M, Ladenstein R, Simon T, Lode H, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834840
Despite highly intensive multimodality treatment regimens, the prognosis of patients with high-risk neuroblastoma (HRNB) and central nervous system (CNS) relapse remains poor. We retrospectively reviewed data from 13 patients with...
14.
Butzer S, Krug B, Reisberg M, Fuchs J, Warmann S, Hubertus J, et al.
Pediatr Blood Cancer
. 2023 Aug;
70(10):e30605.
PMID: 37534915
Background: The pretreatment International Neuroblastoma Risk Group Staging System (INRGSS) discriminates localized tumors L1/L2 depending on the absence/presence of image-defined risk factors (IDRFs) at diagnosis. Referring to this new staging...
15.
Zarghooni K, Bratke G, Landgraf P, Simon T, Maintz D, Eysel P
Dtsch Arztebl Int
. 2023 Apr;
120(24):405-412.
PMID: 37097079
Background: Osteosarcoma and Ewing's sarcoma in children and adolescents require age-specific interdisciplinary diagnosis and treatment to achieve optimal therapeutic outcomes. Methods: The diagnosis and treatment of malignant bone tumors in...
16.
Chiapponi C, Hartmann M, Decarolis B, Simon T, Bruns C, Faust M, et al.
J Clin Res Pediatr Endocrinol
. 2023 Mar;
15(3):257-263.
PMID: 36987773
Objective: Differentiated thyroid cancer (DTC) in adolescents rare but with a favorable outcome, despite higher rates of cervical lymph node and pulmonary metastasis compared to adults. The aim of this...
17.
Ecker J, Selt F, Sturm D, Sill M, Korshunov A, Hirsch S, et al.
Eur J Cancer
. 2023 Mar;
184:200-201.
PMID: 36959034
No abstract available.
18.
Veiga-Canuto D, Cerda-Alberich L, Jimenez-Pastor A, Carot Sierra J, Gomis-Maya A, Sanguesa-Nebot C, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900410
Objectives: To externally validate and assess the accuracy of a previously trained fully automatic nnU-Net CNN algorithm to identify and segment primary neuroblastoma tumors in MR images in a large...
19.
Flaadt T, Ladenstein R, Ebinger M, Lode H, Arnardottir H, Poetschger U, et al.
J Clin Oncol
. 2023 Feb;
41(17):3135-3148.
PMID: 36854071
Purpose: Patients with relapsed high-risk neuroblastoma (rHR-NB) have a poor prognosis. We hypothesized that graft-versus-neuroblastoma effects could be elicited by transplantation of haploidentical stem cells (haplo-SCT) exploiting cytotoxic functions of...
20.
Rosswog C, Fassunke J, Ernst A, Schomig-Markiefka B, Merkelbach-Bruse S, Bartenhagen C, et al.
Br J Cancer
. 2023 Feb;
128(8):1559-1571.
PMID: 36807339
Background: Genomic alterations of the anaplastic lymphoma kinase gene (ALK) occur recurrently in neuroblastoma, a pediatric malignancy of the sympathetic nervous system. However, information on their development over time has...